1 / 74

Pandemic Influenza Avian Influenza

Pandemic Influenza Avian Influenza. Maine Department of Health & Human Services Maine Center for Disease Control & Prevention (formerly Bureau of Health) Dora Anne Mills, M.D., M.P.H. Pandemic Influenza & Avian Influenza 101 Preparedness Efforts College and University Preparedness.

forbes
Download Presentation

Pandemic Influenza Avian Influenza

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pandemic InfluenzaAvian Influenza Maine Department of Health & Human Services Maine Center for Disease Control & Prevention (formerly Bureau of Health) Dora Anne Mills, M.D., M.P.H.

  2. Pandemic Influenza &Avian Influenza 101 • Preparedness Efforts • College and University Preparedness

  3. 1. Pandemic Influenza & Avian Influenza 101

  4. Influenza • Seasonal influenza • Avian influenza • Pandemic influenza

  5. Seasonal Influenza • October – April • Influenza Type A • H3N2, H1N1 • Influenza Type B • Vaccine

  6. Avian Influenza (Bird Flu) • Influenza A • Domestic poultry – can be deadly • High vs. low pathogenic • Wild birds – carriers • Virus in fecal droppings, saliva/nasal discharge

  7. Recent Avian Influenza Outbreaks Affecting Humans • 1997 H5N1 Hong Kong • 1999 H9N2 Hong Kong • 2003 H7N7 Netherlands • 2004 H7N3 Canada • 2004 H5N1 Southeast Asia

  8. Pandemic Influenza • Global outbreak • Highly contagious • Deadly

  9. Recent Pandemics • 1918 Spanish flu (H1N1) • 5,000 deaths in Maine • 500,00 in U.S. • 40,000,000 worldwide • 1957 Asian flu (H2N2) • 70,000 deaths in U.S. • 1-2,000,000 worldwide • 1968 Hong Kong flu (H3N2) • 34,000 deaths in U.S. • 700,000 worldwide

  10. Past Pandemic InfluenzaEstimates for Maine

  11. H5N1 • Detected in Asia since 1997 • Deadly – 50% mortality in humans • Transmitted birds to mammals and limited human to human • Evolving quickly

  12. H5N1 activity as of May 19, 2006 • 217 human cases • In 58 countries • 123 deaths • Mortality rate = 57%

  13. Human Infections and Human Deaths by H5N1 by Month, May 19, 2006 Source: World Health Organization Chart created by the Office of Public Health Emergency Preparedness

  14. 2. Preparedness Efforts • Avian Influenza Preparedness • Pandemic Influenza Preparedness

  15. A. Avian Influenza Preparedness

  16. Detection Testing in: • Migratory birds • Poultry industry

  17. Preparedness Planning • Poultry workers • Backyard flock owners • Others – bird lovers, hunters

  18. General Public • Food safety • Bird handling

  19. B. Pandemic Influenza Preparedness • “Pan Flu”

  20. Significant Issues forPan Flu Planning • Mass Casualty Management • Vaccines Antivirals • Detection and Tracking • Home Care • Hospital Care • Food and Other Support • Transportation of the Critically Ill • Self –Support • Basic Services and Economic Impact • Communication • Quarantine and Isolation

  21. Pandemic Assumptions • Attack rate of 25%-35% • Duration of up to year or more in 2 waves • Each wave lasting 6-8 weeks in community • Healthcare system will be severely taxed if not overwhelmed

  22. Social Disruption fromPandemic Influenza • Absenteeism in essential sectors • Health, law enforcement, food and fuel supplies, education • Economic impact • Psychological stress

  23. 2006 vs 1918 Advantages in 1918 • Smaller population • Less travel • More self-reliance Advantages in 2006 • Healthier population • Better medical care • Preparedness

  24. Federal Preparedness

  25. www.pandemicflu.gov

  26. Surveillance Laboratory Diagnostics Healthcare Planning Infection Control Clinical Guidelines Vaccine Antiviral Drugs Community Disease Control Travel-Related Risks of Disease Communications Workforce Support Components of Federal Plan

  27. Vaccine Antivirals Community Disease Control Selected Components

  28. Vaccines

  29. Assumptions for Vaccination • Two doses will be required • Vaccine will not be available for 3-6 months after start of pandemic • Production will be 3-5 million doses (15 µg)per week

  30. Vaccine Priority Groups • Vaccine and antiviral manufacturers • Health care providers • Persons >65 with >1 high risk conditions • Persons 6 mo to 64 yr with >2 conditions • Persons >6 months with history of hospitalization for pneumonia or influenza • Pregnant women • Household contacts of immunocompromised persons and children <6 months • Public health emergency response workers • Key government leaders

  31. Vaccine Priority Groups (cont) • Healthy people >65 • 6 months to 64 years with 1 high risk condition • Healthy 6-23 months old • Other public health emergency workers • Public safety workers • Utility workers • Transportation workers • Telecommunications workers • Government health decision-makers • Funeral directors • Healthy persons 2-64 years not included above (180 million)

  32. Recommendations for Vaccine and Antivirals may be modified based on: • Virulence • Transmissibility • Drug resistance • Geographic spread • Age-specific attack rates • Morbidity and mortality rates

  33. What You Can Do Now • Annual seasonal influenza vaccination • Pneumococcal vaccination

  34. Antivirals

  35. Antivirals • Adamantanes • Amantadine • Rimantadine • Neuraminidase inhibitors • Oseltamivir (Tamiflu) • Zanamivir (Relenza)

  36. Assumptions for Antivirals • Resistance to adamantanes • Neuraminidase inhibitors will be effective in decreasing morbidity and mortality • Expected domestic capacity for oseltamivir is 1.25 million courses per month • Goal is stockpile of 80 million courses • Current stockpile is 5 million courses

  37. Antiviral Priority Groups • Patients admitted to hospital (T) • Health care workers and EMS providers (T) • Immunocompromised persons and pregnant women (T) • Pandemic health responders and government decision makers (T) • Young children 12-23 months old, persons >65 years old, and persons with underlying medical conditions (T) • Outbreak response in nursing homes (PEP) • 7 Health care workers in ED, ICU, dialysis centers and EMS providers (P)

  38. Antiviral Priority Groups (cont) • Pandemic societal responders and health care workers without direct patient contact (T) • Other outpatients (T) • Highest risk outpatients (P) • Other health care workers with direct patient contact (P) Top 7 groups = 40 million courses

  39. Cost of Antiviral Treatment5-Day Course for an Adult • Amantadine $ 9.50 • Rimantadine $16.10 • Oseltamivir (Tamiflu) $72.10 • Zanamivir (Relenza) $61.80

  40. Personal Stockpiles of Antivirals • Supply • Effectiveness • Resistance • Equity • Shelf life

  41. Stockpiles of Antivirals • Institutional • State

  42. Community Disease Control

  43. Challenges to Containment • Short incubation period • Ability of persons with asymptomatic infection to transmit virus • Early symptoms of illness are likely to be non-specific, delaying recognition

  44. Goal of Community Disease Control • To limit or slow spread of pandemic influenza • Social Distancing

  45. Containment Measures for Ill Individuals • Patient isolation • Management of contacts • Contact tracing • Contact monitoring • Quarantine

  46. Containment Measures For Communities • Promotion of community-wide infection control measures • Snow days and self-shielding • Closure of office buildings, shopping buildings, and public transportation • Widespread community containment (cordon sanitaire)

  47. Containment Measures For Groups of Exposed or At-Risk Persons • Quarantine • Containment measures for specific sites or buildings

  48. Unresolved Issues • Role of airborne transmission • Effectiveness of antivirals • Coordination between states and countries

More Related